Ugur Sahin | CEO and Co-Founder |
Sylke Maas | Vice President of Investor Relations and Strategy |
Ozlem Tureci | Chief Medical Officer and Co-Founder |
Sean Marett | Chief Business and Commercial Officer |
Sierk Poetting | CFO and Chief Operating Officer |
Ryan Richardson | Chief Strategy Officer |
Cory Kasimov | JP Morgan |
Tazeen Ahmad | Bank of America |
Chris Shibutani | Goldman Sachs |
Daina Graybosch | SVB Leerink |
Zhiqiang Shu | Berenberg |
Arlinda Lee | Canaccord |
Simon Baker | Redburn |
Thank you for standing by and welcome to the BioNTech, Second Quarter 2021 Update Call. At this time, all participants are in a listen-only mode. There will be a presentation followed by a question-and-answer session [Operator Instruction] I must advise you the call is being recorded today on Monday, 08/09/2021. I would now like to hand the call over to your Vice President of Investor Relations and Strategy, Sylke Maas. Please go ahead.